Isletech Overview

  • Founded
  • 2009
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Isletech General Information

Description

Developer of patented technologies. The company is engaged in the research, development, and commercialization of patented technologies in the field of transplantation therapy for people with conditions requiring cell-based replacement treatments, with a focus on type 1 or insulin-dependent diabetes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
Primary Office
  • 2360 Corprate Circle
  • Suite 400
  • Henderson, NV 89074
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Isletech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Isletech‘s full profile, request access.

Request a free trial

Isletech Executive Team (1)

Name Title Board Seat Contact Info
Wayne Mower President, Treasurer, Secretary & Director
To view Isletech’s complete executive team members history, request access »